118 related articles for article (PubMed ID: 1458370)
1. Prevention of 5-fluorouracil-induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation.
Nomoto K; Yokokura T; Nomoto K
Can J Microbiol; 1992 Aug; 38(8):774-8. PubMed ID: 1458370
[TBL] [Abstract][Full Text] [Related]
2. Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation.
Nomoto K; Yokokura T; Mitsuyama M; Yoshikai Y; Nomoto K
Antimicrob Agents Chemother; 1992 Feb; 36(2):361-7. PubMed ID: 1605602
[TBL] [Abstract][Full Text] [Related]
3. Induction of lethal infection with indigenous Escherichia coli in mice by fluorouracil.
Nomoto K; Yokokura T; Yoshikai Y; Mitsuyama M; Nomoto K
Can J Microbiol; 1991 Mar; 37(3):244-7. PubMed ID: 1829022
[TBL] [Abstract][Full Text] [Related]
4. Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice.
Kato I; Yokokura T; Mutai M
Cancer Immunol Immunother; 1988; 26(3):215-21. PubMed ID: 3133111
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.
Yu M; Qi R; Chen C; Yin J; Ma S; Shi W; Wu Y; Ge J; Jiang Y; Tang L; Xu Y; Li Y
J Appl Microbiol; 2017 Feb; 122(2):506-515. PubMed ID: 27860074
[TBL] [Abstract][Full Text] [Related]
6. The role of tumor necrosis factor (TNF)-alpha in the antitumor effect of intrapleural injection of Lactobacillus casei strain Shirota in mice.
Yasutake N; Matsuzaki T; Kimura K; Hashimoto S; Yokokura T; Yoshikai Y
Med Microbiol Immunol; 1999 Aug; 188(1):9-14. PubMed ID: 10691088
[TBL] [Abstract][Full Text] [Related]
7. Effects on antitumor activity and cytokine production in the thoracic cavity by intrapleural administration of Lactobacillus casei in tumor-bearing mice.
Matsuzaki T; Hashimoto S; Yokokura T
Med Microbiol Immunol; 1996 Nov; 185(3):157-61. PubMed ID: 9007821
[TBL] [Abstract][Full Text] [Related]
8. [Augmentation of antitumor activity of Lactobacillus casei YIT 8018 (LC 9018) in combination with various antitumor drugs].
Matsuzaki T; Kato I; Yokokura T; Mutai M
Gan To Kagaku Ryoho; 1984 Mar; 11(3):445-51. PubMed ID: 6200079
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of 987P fimbriae of enterotoxigenic Escherichia coli surface-displayed on Lactobacillus casei.
Bai Y; Wang G; Qi H; Wang Y; Xu C; Yue L; Hou X; Yu L
Res Vet Sci; 2020 Feb; 128():308-314. PubMed ID: 31901569
[TBL] [Abstract][Full Text] [Related]
10. Protection of mice against herpes simplex virus infection by a Lactobacillus casei preparation (LC 9018) in combination with inactivated viral antigen.
Watanabe T; Saito H
Microbiol Immunol; 1986; 30(2):111-22. PubMed ID: 3012292
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model.
Nomoto K; Matsuoka Y; Hayakawa K; Ohwaki M; Kan T; Yoshikai Y; Nomoto K
Med Microbiol Immunol; 1992; 181(2):87-98. PubMed ID: 1406460
[TBL] [Abstract][Full Text] [Related]
12. Host-mediated antitumor activity of Lactobacillus casei in mice.
Yasutake N; Kato I; Ohwaki M; Yokokura T; Mutai M
Gan; 1984 Jan; 75(1):72-80. PubMed ID: 6427051
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice.
Miake S; Nomoto K; Yokokura T; Yoshikai Y; Mutai M; Nomoto K
Infect Immun; 1985 May; 48(2):480-5. PubMed ID: 3921464
[TBL] [Abstract][Full Text] [Related]
14. Oxygen radical production by peritoneal macrophages and Kupffer cells elicited with Lactobacillus casei.
Hashimoto S; Nomoto K; Matsuzaki T; Yokokura T; Mutai M
Infect Immun; 1984 Apr; 44(1):61-7. PubMed ID: 6423544
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of a recombinant and a mutein type of granulocyte colony stimulating factor on the growth of Meth-A fibrosarcoma with 5-fluorouracil chemotherapy.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Fukumoto M; Tobe T
Biotherapy; 1992; 4(2):81-6. PubMed ID: 1377928
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei.
Yokokura T; Nomoto K; Shimizu T; Nomoto K
Infect Immun; 1986 Apr; 52(1):156-60. PubMed ID: 3082755
[TBL] [Abstract][Full Text] [Related]
17. Induction of tumoricidal peritoneal exudate cells by administration of Lactobacillus casei.
Kato I; Yokokura T; Mutai M
Int J Immunopharmacol; 1985; 7(1):103-9. PubMed ID: 3158616
[TBL] [Abstract][Full Text] [Related]
18. Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein.
Liu JK; Hou XL; Wei CH; Yu LY; He XJ; Wang GH; Lee JS; Kim CJ
Appl Environ Microbiol; 2009 Jul; 75(13):4491-7. PubMed ID: 19447955
[TBL] [Abstract][Full Text] [Related]
19. Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.
Wen LJ; Hou XL; Wang GH; Yu LY; Wei XM; Liu JK; Liu Q; Wei CH
Vaccine; 2012 May; 30(22):3339-49. PubMed ID: 21856357
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antitumor activity of Lactobacillus casei with other bacterial immunopotentiators.
Yasutake N; Ohwaki M; Yokokura T; Mutai M
Med Microbiol Immunol; 1984; 173(3):113-25. PubMed ID: 6438456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
